Literature DB >> 32659873

QT and outcomes in cirrhosis: A prolonged debate on causality in need of correction.

Nikhilesh R Mazumder1, Lisa B VanWagner1,2.   

Abstract

Entities:  

Keywords:  cardiovascular disease; clinical research/practice; health services and outcomes research; liver disease; liver transplantation/hepatology

Mesh：

Year:  2020        PMID： 32659873      PMCID： PMC7855464          DOI： 10.1111/ajt.16209

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   9.369


× No keyword cloud information.
  13 in total

1.  Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis.

Authors:  Jens H Henriksen; Flemming Bendtsen; Erik Feldager Hansen; Søren Møller
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

2.  QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis.

Authors:  Franco Trevisani; Antonio Di Micoli; Andrea Zambruni; Maurizio Biselli; Valentina Santi; Virginia Erroi; Barbara Lenzi; Paolo Caraceni; Marco Domenicali; Mario Cavazza; Mauro Bernardi
Journal:  Liver Int       Date:  2012-07-10       Impact factor: 5.828

3.  Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis.

Authors:  L Puthumana; V Chaudhry; P J Thuluvath
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

4.  Redefining Cirrhotic Cardiomyopathy for the Modern Era.

Authors:  Manhal Izzy; Lisa B VanWagner; Grace Lin; Mario Altieri; James Y Findlay; Jae K Oh; Kymberly D Watt; Samuel S Lee
Journal:  Hepatology       Date:  2019-10-11       Impact factor: 17.425

5.  High early cardiovascular mortality after liver transplantation.

Authors:  Lisa B VanWagner; Brittany Lapin; Josh Levitsky; John T Wilkins; Michael M Abecassis; Anton I Skaro; Donald M Lloyd-Jones
Journal:  Liver Transpl       Date:  2014-10-24       Impact factor: 5.799

Review 6.  What clinicians should know about the QT interval.

Authors:  Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Robert M Califf
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; David D Douglas
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.

Authors:  L B VanWagner; M Serper; R Kang; J Levitsky; S Hohmann; M Abecassis; A Skaro; D M Lloyd-Jones
Journal:  Am J Transplant       Date:  2016-03-29       Impact factor: 8.086

9.  Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.

Authors:  Andrea Zambruni; Franco Trevisani; Antonio Di Micoli; Francesco Savelli; Annalisa Berzigotti; Eleonora Bracci; Paolo Caraceni; Marco Domenicali; Palmiro Felline; Marco Zoli; Mauro Bernardi
Journal:  J Hepatol       Date:  2007-12-26       Impact factor: 25.083

Review 10.  Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ying Peng; Xingshun Qi; Xiaozhong Guo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889
View more
  1 in total

Review 1.  Cardiac evaluation of the kidney or liver transplant candidate.

Authors:  Paul Emile Levy; Sadiya S Khan; Lisa B VanWagner
Journal:  Curr Opin Organ Transplant       Date:  2021-02-01       Impact factor: 2.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.